According to Research by SNS Insider, Global Laboratory Developed Tests Market Growth is Fueled by Rising Demand for Personalized Diagnostics and Chronic Disease Detection.Austin, Aug. 05, 2025 (GLOBE ...

The laboratory-developed test market in North America is predicted to grow at a 5.1% CAGR until 2034. Laboratory-grade diagnoses are predicted to account for 86.5% of revenue in the United States ...

The pregnancy-test–like tool—which works in only 10 minutes—is 500 percent more sensitive than current laboratory tests, ...

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory ...

Quanterix’ LDT – the first pTau-181 plasma test released for clinical use in the U.S. – is a quantitative immunoassay intended for the measurement of pTau-181 concentration in human plasma.

In this interview, News Medical speaks with SPT Labtech about utilizing the firefly for Laboratory Developed Tests (LDT), specifically for the field of NGS library prep-based LDT.

Laboratory-developed tests have long skirted FDA oversight, though the agency has always maintained that it has the authority to step in. Debate over regulating the space stretches back to the ...

The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way according ...

VANCOUVER — Cannabix Technologies Inc. reports that Omega Laboratories Inc., a drug testing laboratory, has delivered a Validation Packet for Omega’s Laboratory Developed Test Method to test ...